163 related articles for article (PubMed ID: 22344297)
21. [Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].
Satoshi I; Narita M; Ozeki A; Nakamura A; Hashimoto S; Narita M; Kuzumaki N; Uezono Y; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):169-76. PubMed ID: 19108502
[TBL] [Abstract][Full Text] [Related]
22. Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.
Koshimizu TA; Honda K; Nagaoka-Uozumi S; Ichimura A; Kimura I; Nakaya M; Sakai N; Shibata K; Ushijima K; Fujimura A; Hirasawa A; Kurose H; Tsujimoto G; Tanoue A; Takano Y
Nat Neurosci; 2018 Jun; 21(6):820-833. PubMed ID: 29713080
[TBL] [Abstract][Full Text] [Related]
23. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
24. Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura.
De Pas T; Toffalorio F; Colombo P; Trifirò G; Pelosi G; Vigna PD; Manzotti M; Agostini M; de Braud F
J Thorac Oncol; 2008 Aug; 3(8):938-41. PubMed ID: 18670317
[TBL] [Abstract][Full Text] [Related]
25. Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration.
Chandran P; Sluka KA
Pain; 2003 Mar; 102(1-2):195-201. PubMed ID: 12620611
[TBL] [Abstract][Full Text] [Related]
26. Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner.
Dai WL; Liu XT; Bao YN; Yan B; Jiang N; Yu BY; Liu JH
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30429454
[TBL] [Abstract][Full Text] [Related]
27. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
28. μ Opioid Receptor-Triggered Notch-1 Activation Contributes to Morphine Tolerance: Role of Neuron-Glia Communication.
Sanna MD; Borgonetti V; Galeotti N
Mol Neurobiol; 2020 Jan; 57(1):331-345. PubMed ID: 31347026
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
30. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.
Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S
J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033
[TBL] [Abstract][Full Text] [Related]
31. In vivo PDGF beta receptor activation in the dorsocaudal brainstem of the rat prevents hypoxia-induced apoptosis via activation of Akt and BAD.
Simakajornboon N; Szerlip NJ; Gozal E; Anonetapipat JW; Gozal D
Brain Res; 2001 Mar; 895(1-2):111-8. PubMed ID: 11259767
[TBL] [Abstract][Full Text] [Related]
32. Morphine stimulates platelet-derived growth factor receptor-β signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo.
Weber ML; Chen C; Li Y; Farooqui M; Nguyen J; Poonawala T; Hebbel RP; Gupta K
Br J Anaesth; 2013 Dec; 111(6):1004-12. PubMed ID: 23820675
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells.
Fred RG; Boddeti SK; Lundberg M; Welsh N
Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476
[TBL] [Abstract][Full Text] [Related]
34. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Ma LK; Li Q; He LF; Hua JS; Zhou JL; Yu H; Feng KF; Chen HW; Hu H; Wang L
Arq Bras Cardiol; 2012 Dec; 99(6):1082-91. PubMed ID: 23184075
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of radiation-induced skin fibrosis with imatinib.
Horton JA; Chung EJ; Hudak KE; Sowers A; Thetford A; White AO; Mitchell JB; Citrin DE
Int J Radiat Biol; 2013 Mar; 89(3):162-70. PubMed ID: 23083077
[TBL] [Abstract][Full Text] [Related]
36. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo.
Kelly DJ; Cox AJ; Gow RM; Zhang Y; Kemp BE; Gilbert RE
Hypertension; 2004 Aug; 44(2):195-202. PubMed ID: 15197170
[TBL] [Abstract][Full Text] [Related]
38. A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571.
Böhmer FD; Karagyozov L; Uecker A; Serve H; Botzki A; Mahboobi S; Dove S
J Biol Chem; 2003 Feb; 278(7):5148-55. PubMed ID: 12435730
[TBL] [Abstract][Full Text] [Related]
39. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
40. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
